|
Interview with Jeff Boyd, PhD.
Dr. Jeff Boyd is Senior Vice President and Chief Scientific Officer of the Fox Chase Cancer Center in Philadelphia, PA. In November 2009 he was appointed Chair of OCRF's Scientific Advisory Committee. In this interview with OCRF's Sarah DeFeo, Dr. Boyd shares his thoughts on the most promising areas of ovarian cancer research, and how OCRF is uniquely positioned to make a real impact on the disease. |
|
Read more...
|
|
|
Dr. Kathryn Terry on the Genetics of Ovarian Cancer.
Kathryn Terry, ScD is an Assistant Professor of Obstetrics, Gynecology, and Reproductive Biology att he Harvard Medical School/Brigham and Women's Hospital in Boston, MA. She received an OCRF Liz Tilberis award in both 2006 and 2009. She was interviewed by OCRF's Director of Grants, Sarah DeFeo. |
|
Read more...
|
|
Q&A With Mitchell Ho, Ph.D.
Dr. Mitchell Ho is a Principal Investigator and Head of the Antibody Therapy Unit in the Laboratory of Molecular Biology at the National Cancer Institute. He is a 2007 recipient of OCRF's Individual Investigator Award. |
|
Read more...
|
|
Q&A With Tian-Li Wang, PhD
Dr. Tian-Li Wang is an Assistant Professor in the Department of Obstetrics and Gynecology at the Johns Hopkins Medical Institution in Baltimore, Maryland. She is the recipient of an OCRF Individual Investigator Award. |
|
Read more...
|
|
Dr. Gary Leiserowitz on the Biggest Challenge in Ovarian Cancer Research
Dr. Gary Leiserowitz is a Professor, and Chief of the Division of Gynecologic Oncology at the University of California, Davis Medical Center. He is a 2008 recipient of OCRF's largest and most prestigious grant, the Program Project Development Grant. |
|
Read more...
|
|
|
|
|
|
|
Page 1 of 3 |
